Denka Company Limited
Announcement on Formulation of Management Plan ‘Mission 2030’ Phase 2 (Fiscal Years 2026–2028)
Denka has formulated Phase 2 of its management plan for fiscal years 2026 to 2028, targeting operating income of 35 billion yen to 45 billion yen and ROE of 6.0% to 8.0%, aiming to balance growth strategies with financial discipline.
Key Figures
- Operating Income (Forecast for 2025): 25 billion yen
- Operating Income (2026–2028): 35 billion yen to 45 billion yen
- ROE (Forecast for 2025): 5.1% → 8.0% (Target for 2028)
AI要約
Overview of Management Plan 'Mission 2030' Phase 2
Denka Company Limited positions the Phase 2 period of fiscal years 2026 to 2028 around the key priority of 'Rebuilding earning power and establishing a foundation for a new growth stage,' setting the goals of achieving record-high operating income and attaining 8% ROE. While Phase 1 saw slowed growth due to declining profitability and changes in the EV market, Phase 2 aims to balance growth strategies, structural reforms, and financial discipline. The company will clarify directions such as 'growth drivers,' 'stable growth,' and 'cash cows' for each business domain, promoting strategic expansion and improved capital efficiency.
Details of Financial Targets and Growth Strategies
Operating income is targeted to rise from 35 billion yen in 2026 to 45 billion yen in 2028, with ROE aiming from 6.0% to 8.0%, and improvement of the D/E ratio to 0.7 or below. Investment amounts are planned to decrease from 61 billion yen in Phase 1 to lower levels in Phase 2 through focused investments. The company has set three core business domains: ICT & Energy, Healthcare, and Sustainable Living. In ICT & Energy, key materials supply in mega-trend areas will be pursued; Healthcare will focus on stable growth of the diagnostic reagents business; and Sustainable Living will optimize business chains and advance the cash cow transformation.
